Condition: Hip Arthropathy Associated With Other Conditions · Sponsor: Universitaire Ziekenhuizen KU Leuven
Total hip arthroplasty (THA) volumes continue to rise each year as the population ages and indications broaden. Increasingly, younger patients require hip replacement for conditions beyond primary osteoarthritis or fractures. As a result, the number of revision procedures is growing and is expected to increase further. Prospective data collection within this population will enable us to address key uncertainties, particularly around optimal implant selection for complex primary and revision cases. In addition, establishing a structured prospective database will allow for systematic internal auditing for quality assurance. Even simple metrics - such as verifying whether every patient received a complete diagnostic infection workup before revision surgery - could immediately enhance service quality and inform improvements to clinical pathways.
This description comes directly from the study's public registry record.
Stijn Ghijselings, Dr. · +32 16 33 88 72 · stijn.ghijselings@uzleuven.be
Anna Tarasiuk · +32 16 33 88 18 · orthopedie.research@uzleuven.be
Always discuss trial participation with your own doctor first.
| Universitaire Ziekenhuizen KU Leuven | Leuven, Vlaams-Brabant, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07481448